Yırtıklı Retina Dekolmanında Ameliyat Mikroskopu Altında Yapılan Skleral Çökertme Cerrahisi ile Ameliyat Mikroskopu Kullanılmadan Yapılan Skleral Çökertme Cerrahisinin Karşılaştırılması

Objectives: To compare the results of scleral buckling surgery with and without use of operating microscope for primary rhegmatogenous\udretinal detachment (RRD).\udMaterials and Methods: This comparative study consisted of 74 eyes of 74 patients who underwent scleral buckling for primary\udRRD. Group 1 consisted of 35 patients (17 male and 18 female) who were operated using operating microscope and Group 2 consisted\udof 39 patients (19 male and 20 female) who were operated without operating microscope. Patients with post-equatorial breaks, retinal\udbreaks greater than 90°, proliferative vitreoretinopathy (≥C2), and those with follow-up period of less than sıx months were excluded from\udthe study. The two groups were compared based on age, sex, etiology, anatomic success, and surgical complications (scleral perforation,\udiatrogenic retinal breaks, vitreous hemorrhage, buckle malposition, and vortex vein damage).\udResults: Mean age was 64.11±7.91 years (range, 55-79 years) in Group 1 and 65.20±6.15 years (range, 56-80 years,) in Group 2.\udMean age and gender were not statistically significantly different between the groups (p=0.508 and p=0.990, respectively). Etiological\udcauses were revealed as myopia, peripheral retinal degeneration, pseudophakia, aphakia, trauma, and idiopathic. Etiological causes were\udnot significantly different between the two groups (p>0.05, for all). Surgical complication rates were higher in Group 2, however, the\uddifferences were not statistically significant (p>0.05, for all). Anatomical success rates was similar between the two groups (80% in\udGroup 1 and 79.5% in Group 2, p=0.956).\udConclusion: The results of scleral buckling surgery with and without use of operating microscope were not significantly different;\udHowever, operating microscope should be used especially in presence of risk factors for scleral complications. (Turk J Ophthalmol 2014;\ud44: 175-8